Rating History for Harpoon Therapeutics (HARP) by Citi
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/26/2024 | Yigal Nochomovitz | Downgrade | Neutral (Buy) |
23.00 (13.00) |
22.93 (23.01) |
0.35% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/26/2024 | Yigal Nochomovitz | Downgrade | Neutral (Buy) |
23.00 (13.00) |
22.93 (23.01) |
0.35% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||